Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. DPOH name: BURNETT, JESSICA
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

Refine monthly communication reports results by

Type Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (4)
Results: 1-4 | Export
  1. Heart and Stroke Foundation of Canada / Fondation des maladies du coeur et de l’AVC
    Type: In-house Organization
    Occurred: 2023-09-13
    Posted: 2023-10-16
    Designated public office holders:
    • Bobby Chauhan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Lisa Thompson, Senior Policy Advisor, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Jessica Burnett, Senior Policy Analyst, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Jennifer Boutin, Acting Director, Canada Drug Agency Transition Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  2. Heart and Stroke Foundation of Canada / Fondation des maladies du coeur et de l’AVC
    Type: In-house Organization
    Occurred: 2023-03-06
    Posted: 2023-04-16
    Designated public office holders:
    • Bobby Chauhan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Jessica Burnett, Senior Policy Analyst, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Amanda Pinke, Senior Policy Analyst, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Lisa Thompson, Senior Policy Analyst, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Bourdreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Margaret Sharp, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Jennifer Boutin, Acting Director, Canada Drug Agency Transition Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  3. CANADIAN CANCER SOCIETY / Société canadienne du cancer
    Type: In-house Organization
    Occurred: 2023-02-02
    Posted: 2023-03-15
    Designated public office holders:
    • Jessica Burnett, Senior Policy Analyst, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Amanda Pinke, Policy Analyst | Health Canada (HC)
    • Bobby Chauhan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  4. Heart and Stroke Foundation of Canada / Fondation des maladies du coeur et de l’AVC
    Type: In-house Organization
    Occurred: 2022-11-24
    Posted: 2022-12-15
    Designated public office holders:
    • Margaret Sharp, Director, Pharmaceutical Management Strategies | Health Canada (HC)
    • Julia Oliver, Policy Analyst, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Bobby Chauhan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Jennifer Boutin, Senior Policy Analyst, Canada Drug Agency Transition Office | Health Canada (HC)
    • Michelle Bourdreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Jessica Burnett, Senior Policy Analyst, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
Date Modified: